We are live on ! Find out more
CC

Carlson Capital Portfolio holdings

AUM $318M
1-Year Est. Return 27.64%
This Fund
S&P 500
This Quarter Est. Return
-1.79%
1 Year Est. Return
+27.64%
3 Year Est. Return
+72.52%
5 Year Est. Return
+198.38%
10 Year Est. Return
+1,031.43%
AUM
$1.45B
AUM Growth
-$6.87M
Cap. Flow
+$79.9M
Cap. Flow %
5.49%
Top 10 Hldgs %
42.52%
Holding
192
New
41
Increased
44
Reduced
27
Closed
68

Top Buys

Rank Stock Value
1
Y
Alleghany Corp
Y
+$66.1M
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$65.1M
3
DRE
Duke Realty Corp.
DRE
+$49.3M
4
BKI
Black Knight, Inc. Common Stock
BKI
+$39.7M
5
BAC icon
Bank of America
BAC
+$34.9M

Top Sells

Rank Stock Value
1
CERN
Cerner Corp
CERN
+$77.2M
2
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$59.1M
3
PNC icon
PNC Financial Services
PNC
+$25.7M
4
BBD icon
Banco Bradesco
BBD
+$21M
5
WTW icon
Willis Towers Watson
WTW
+$17M

Sector Composition

Rank Sector Weight
1 Financials 35.45%
2 Technology 17.63%
3 Healthcare 12.26%
4 Industrials 8.28%
5 Consumer Discretionary 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LKFT
101
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
$1.95M 0.13%
35,000
– –
JWSM.U
102
DELISTED
Jaws Mustang Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
JWSM.U
$1.9M 0.13%
192,488
– –
TSLA icon
103
PUT
Tesla
TSLA
$1.21T
$1.7M 0.12%
1,710
+1,410
+470% +$385K
TFFP
104
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$1.7M 0.12%
12,000
-400
-3% -$55.8K
RBAC
105
DELISTED
RedBall Acquisition Corp.
RBAC
$1.68M 0.12%
168,397
– –
IOVA icon
106
Iovance Biotherapeutics
IOVA
$2.13B
$1.66M 0.11%
150,000
+50,000
+50% +$655K
SNFCA icon
107
Security National Financial
SNFCA
$255M
$1.51M 0.1%
216,748
+50,831
+31% +$370K
CUE icon
108
Cue Biopharma
CUE
$131M
$1.44M 0.1%
19,333
+5,833
+43% +$682K
APTO
109
DELISTED
Aptose Biosciences, Inc.
APTO
$1.42M 0.1%
4,239
+762
+22% +$365K
QURE icon
110
uniQure
QURE
$2.46B
$1.37M 0.09%
73,396
-5,000
-6% -$79.5K
QQQ icon
111
PUT
Invesco QQQ Trust
QQQ
$446B
$1.36M 0.09%
1,000
+100
+11% +$31K
TEAM icon
112
Atlassian
TEAM
$25.9B
$1.2M 0.08%
+6,400
New +$1.37M
LTRN icon
113
Lantern Pharma
LTRN
$34.3M
$971K 0.07%
170,000
+2,700
+2% +$16.1K
TWTR
114
PUT
DELISTED
Twitter, Inc.
TWTR
$865K 0.06%
+2,000
New +$85.8K
LITS
115
Lite Strategy Inc
LITS
$33.4M
$666K 0.05%
55,000
+29,000
+112% +$316K
TSHA icon
116
Taysha Gene Therapies
TSHA
$1.57B
$614K 0.04%
+165,000
New +$655K
SMR icon
117
NuScale Power
SMR
$2.85B
$500K 0.03%
+50,000
New +$500K
EIGR
118
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$410K 0.03%
2,167
+1,267
+141% +$255K
GLD icon
119
CALL
SPDR Gold Trust
GLD
$131B
$374K 0.03%
2,000
-2,100
-51% -$367K
CMBT
120
CMB.TECH NV
CMBT
$4.45B
$321K 0.02%
+26,888
New +$323K
TE
121
PUT
T1 Energy
TE
$1.18B
$225K 0.02%
+1,000
New +$8.76K
XCUR icon
122
Exicure
XCUR
$10.7M
$216K 0.01%
20,000
+10,667
+114% +$224K
SMR.WS
123
DELISTED
NuScale Power Corporation Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
SMR.WS
$177K 0.01%
+87,000
New +$203K
HMCOW
124
DELISTED
HumanCo Acquisition Corp. Warrant
HMCOW
$55K ﹤0.01%
479,025
+90,000
+23% +$24K
AES icon
125
AES
AES
$10.6B
– –
-129,467
Closed -$3.33M
3 4
5
6 7

Similar funds

EFN
Equita Financial Network Fort Washington, Pennsylvania $318M AUM 16.52% 1-Year Est. Return
WIS
Wright Investors Service Shelton, Connecticut $318M AUM 33.9% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
TM
TigerOak Management Albuquerque, New Mexico $317M AUM 25.39% 1-Year Est. Return
GWP
Gen-Wealth Partners Zeeland, Michigan $317M AUM 17.24% 1-Year Est. Return
CPW
Crestmont Private Wealth Houston, Texas $317M AUM 15.31% 1-Year Est. Return
KI
Keewaydin Investments Southampton, New York $317M AUM
CPH
C Partners Holding Zurich, Switzerland $317M AUM 4.76% 1-Year Est. Return

Carlson Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Carlson Capital held 192 positions worth $1.45B, down 0.47% from $1.46B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Carlson Capital deployed $79.9M of net new capital in Q2 2022, opening 41 new positions and adding to 44 existing holdings. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 510,000 shares worth $74.3M.

By sector, the portfolio is most concentrated in Financials at 35% of assets, up from 33% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Willis Towers Watson, an estimated $17M trimmed.

  • Carlson Capital's largest Q2 2022 buy was Biohaven Pharmaceutical Holding Company Ltd.: 510,000 shares worth $74.3M.
  • Carlson Capital added most to Alleghany Corp in Q2 2022, an estimated $66.1M increase.
  • Carlson Capital's biggest Q2 2022 reduction was Willis Towers Watson, cutting an estimated $17M.
  • Carlson Capital fully exited Cerner Corp in Q2 2022, selling an estimated $77.2M.
  • Carlson Capital's ten largest holdings make up 43% of its $1.45B portfolio in Q2 2022.
  • Carlson Capital opened 41 new positions and closed 68 in Q2 2022.
  • Carlson Capital's portfolio value fell 0.47% quarter-over-quarter to $1.45B.

Based on Carlson Capital's 13F filing for Q2 2022, filed 15 Aug 2022.